Screening for cancer of the colon and rectum A review on incidence, mortality, cost and benefit

• Published in: Laeknabladid Vol. 107; no. 9; pp. 398 - 405
• Main Authors: Birgisson, Helgi, Ólafsdóttir, Elínborg J., Sverrisdóttir, Anna, Einarsson, Sigurður, Smáradóttir, Agnes, Tryggvadóttir, Laufey
• Format: Journal Article
• Language: English
• Published: 03.09.2021
• ISSN: 0023-7213; 1670-4959
• DOI: 10.17992/lbl.2021.09.65

Key words: Colorectal cancer, Screening, Incidence, Mortality, Cost-effectiveness In this article the incidence and mortality for cancer of the colon and rectum in Iceland is discussed. The two most common screening methods, faecal immunochemical test (FIT) and colonoscopy are compared and an estimate of cost and benefits for the Icelandic society will be made. The incidence of cancer of the colon and rectum has been increasing in Iceland in last decades but mortality has decreased and survival improved. However, more individuals die from cancer of the colon and rectum than from both breast- and cervical cancer added together. It is likely that screening for cancer of the colon and rectum, could prevent at least 6 of the 28 deaths related to those cancers, occurring yearly in Iceland in screening age, given a screening ages of 50-74 years. The extra cost for the Icelandic community due to the implementation of screening for cancer of the colon and rectum will be acceptable due to the lower cost of simpler treatments, lower cancer incidence and reduced mortality.